StimulusBio and Gulf Coast Blood Partner to Support Medical Breakthroughs Through Innovated Blood Products
HOUSTON, TX — Gulf Coast Blood and StimulusBio are proud to announce a new partnership aimed at bringing innovation and impact to the community. Together, the organizations will collaborate on initiatives that enhance how blood products and biospecimens can be improved for applications in lifesaving therapeutics and to support cutting-edge medical research.
The partnership comes at a time when the demand for high-quality biospecimens and advanced biotherapy solutions is rapidly increasing. Health systems and research organizations are seeking faster, more reliable ways to access the materials needed to support new treatments, clinical trials, and next generation diagnostics. This collaboration equips both organizations to respond to these needs with greater speed, scale, and community impact.
Gulf Coast Blood, a leading nonprofit dedicated to partnering with the community to save and sustain lives through blood donation, continues to expand its role as a center of excellence in blood and biotherapies. StimulusBio, a Houston-based life sciences company known for its market-driven, customer-focused approach to complex product development, brings complementary expertise to the collaboration.
For Gulf Coast’s donor community, made up of thousands of individuals who give selflessly each year, this partnership creates new opportunities for local blood donors to make a significant impact.
“Our donors are at the heart of everything we do,” said Nikhil Nayak, President and CEO at Gulf Coast Blood. “Partnering with StimulusBio allows us to explore new ways that their generous donations can support medical breakthroughs and help even more patients.”
The partnership brings together the strength of Gulf Coast’s donor network with StimulusBio’s capabilities in developing innovative, real-world solutions for life sciences. The two organizations will collaborate to expand the use of each donation and explore new applications that benefit patients across Texas and beyond.
Together, the partners will identify opportunities that address a growing demand in biotherapies, clinical research, and advanced diagnostics. Each initiative will be structured to accelerate time to market, improve scalability, and support solutions that can be adopted across the industry.
“By pairing StimulusBio’s innovation engine with Gulf Coast’s operational strength, we are positioned to bring highly impactful solutions to market quickly and efficiently,” said Mimi Healy, CEO of StimulusBio. “This partnership enables us to more fully meet the evolving needs of healthcare systems, research sponsors, and biotechnology companies.”
The two organizations have been aggressively working to bring to market their first product that will directly impact lifesaving treatments around the world.
About Gulf Coast Blood
Gulf Coast Blood is a nonprofit organization committed to saving and sustaining lives. Serving the Texas Gulf Coast
region, it provides a safe, robust blood supply and drives innovation across blood and biotherapies.
Media Contact: Stephanie Jacksis
Corporate Communications Manager
sjacksis@giveblood.org
About StimulusBio
StimulusBio develops innovative, market-ready solutions across cell & gene therapy, product development, and life
science operations. The company partners with health systems, research organizations, and biotechnology firms to
bring high impact products to market.
Media Contact: Stacie Frye
Chief Commercial Officer
stacie@stimulusbio.com